Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer

Abstract

Colon cancer (CC) is a disease with high incidence and mortality rate. The interaction between epithelial-mesenchymal transition (EMT) and immune status has important clinical significance. We aim to identify EMT-immune-related prognostic biomarkers in colon cancer. The GEO2R and GEPIA 2.0 were utilized to calculate the differential expression genes between CC and normal mucosa. Immport, InnateDB and EMTome databases were used to define EMT-immune-related genes. We conducted batch prognostic analysis by TCGA data. The expression patterns were verified by multiple datasets and lab experiments. GEPIA 2.0 and TIMER 2.0 were utilized to analyze the correlation of the hub genes with EMT markers and immune infiltration. GeneMANIA, STRING, and Metascape were used for co-expression and pathway enrichment analysis. Finally, we established a signature by the method of multivariate Cox regression analysis. CDKN2A, CMTM8 and ILK were filtered out as prognostic genes. CDKN2A and CMTM8 were up-regulated, while ILK was down-regulated in CC. CDKN2A was positively correlated with infiltration of macrophages, Th2 cells, Treg cells, and negatively correlated with NK cells. CMTM8 was negatively correlated with CD8+ T cells, dendritic cells, and NK cells. ILK was positively correlated with CD8+ T cells and dendritic cells. Moreover, CDKN2A, CMTM8 and ILK were significantly correlated with EMT markers. The three genes could participate in the TGF-β pathway. The prognosis model established by the three hub genes was an independent prognosis factor, which can better predict the prognosis. CDKN2A, CMTM8 and ILK are promising prognostic biomarkers and may be potential therapeutic targets in colon cancer.

Epithelial-Mesenchymal Transition Gene Signature Is Associated with Neoadjuvant Chemoradiotherapy Resistance and Prognosis of Esophageal Squamous Cell Carcinoma

“…It is possible that this is the reason why people with high EMT scores have a poorer prognosis. EMT may interact with immunosuppres-sion either directly or indirectly, as shown by the results of a prior study [33]. Since immune cells are important biomarkers for immunotherapy, the influence of EMT on immunity is important and needs more studies.…”

Construction of cuproptosis‑associated prognostic signature in colon adenocarcinoma based on bioinformatics and RT‑qPCR analysis

“…CDKN2A can be regarded as a promising biomarker of colon cancer ( 26 ). CDKN2A , as an important marker of epithelial-mesenchymal transition, tends to be upregulated in colon cancer ( 27 ). Cluster B had more mortality and advanced stage (stage III–IV) compared with cluster A.…”

Pan‐cancer analyses reveal molecular and clinical characteristics of cuproptosis regulators

“…Furthermore, although the oncogenic effects of mutations and loss of CDKN2A are well established [53], unexpectedly high CDKN2A expression indicates a poor prognosis in a variety of tumors. Similarly, previous studies have shown that high CDKN2A expression is associated with poor prognosis in LIHC, COAD, and BLCA [54–57]. However, the mechanism by which CDKN2A acts as a tumor suppressor but leads to poor prognosis has not been clarified.…”